Ambee Pharmaceuticals Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Millions BDT. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 12, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Capitalization	1,832	1,960	1,829	1,318	1,260	985
Market Cap Growth	1.10%	7.12%	38.81%	4.57%	27.92%	-14.60%
Enterprise Value	2,395	2,445	2,240	1,629	1,521	1,202
Last Close Price	763.50	815.42	760.13	546.57	521.71	407.85
PE Ratio	331.51	369.08	188.91	144.98	156.37	-
PS Ratio	11.63	8.50	8.34	6.65	6.96	9.95
PB Ratio	51.82	60.61	62.17	56.46	23.92	21.97
P/TBV Ratio	51.82	60.61	62.17	56.46	23.92	21.97
P/OCF Ratio	-	90.16	-	-	-	-
EV/Sales Ratio	15.20	10.61	10.22	8.22	8.40	12.14
EV/EBITDA Ratio	267.80	196.29	122.73	80.79	77.41	-
EV/EBIT Ratio	-	330.94	180.50	123.64	102.35	-
Debt / Equity Ratio	18.68	19.76	0.03	16.82	6.55	5.35
Debt / EBITDA Ratio	73.85	49.53	0.05	18.95	16.49	-
Net Debt / Equity Ratio	15.91	15.66	-1.08	15.59	6.22	5.01
Net Debt / EBITDA Ratio	66.20	40.65	-1.75	18.05	16.70	-134.45
Net Debt / FCF Ratio	-30.56	-245.76	0.47	-10.30	-4.39	-41.23
Asset Turnover	0.21	0.35	0.40	0.39	0.39	0.23
Inventory Turnover	0.36	0.55	0.49	0.49	0.54	0.40
Quick Ratio	0.44	0.47	0.38	0.34	0.29	0.29
Current Ratio	0.85	0.83	0.91	0.88	0.92	0.87
Return on Equity (ROE)	16.36%	17.19%	36.70%	23.91%	16.53%	-25.34%
Return on Assets (ROA)	0.34%	0.70%	1.41%	1.62%	2.01%	-1.07%
Return on Invested Capital (ROIC)	0.50%	2.00%	5.28%	2.92%	3.60%	-2.68%
Return on Capital Employed (ROCE)	10.40%	20.30%	36.30%	44.70%	24.80%	-13.70%
Earnings Yield	0.30%	0.27%	0.53%	0.69%	0.64%	-1.32%
FCF Yield	-1.00%	-0.10%	-3.72%	-2.68%	-5.93%	-0.55%
Dividend Yield	0.13%	0.12%	0.13%	0.27%	0.19%	-
Payout Ratio	39.37%	44.23%	34.91%	11.00%	18.61%	-
Total Shareholder Return	0.13%	0.12%	0.13%	0.27%	0.19%	-